Larvol Delta - STENOVA--A-Study-to-Evaluate-Safety-Tolerability-PK-and-PD-of-AGMB129-in-Patients-With-Fibrostenotic-Crohn39s-Disease

ontunisertib (AGMB-129) - AgomAb Therapeutics

http://clinicaltrials.gov/ct2/show/NCT05843578

Jul 10, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next